An incident reporting incorrect birth control packaging leads to pregnancies and a lawsuit from the 113 women who claimed to have used the product, yet not received the wanted results. It’s natural reassurance that when a customer picks up the birth controls from the pharmacy that they will be placed in the right order.
It’s a crucial part of the packaging, as most of them are a mix of active hormonal contraception and placebo pills during some of the days. This is for easily remembering, and not make mistakes for something that is so important. By disrupting that pattern, the faulty packaging may result in unwanted pregnancies.
And, reportedly, it did for 113 women across 28 states who are now suing the pharmaceutical company Qualitest, a subsidiary of Irish company Endo Pharmaceuticals. The lawsuit was filed in Philadelphia court, as the patients claimed the packaging was faulty and the pills were thus unsafe.
The arrangement of the pills was reversed 180 degrees, which made it likely for the patient to take a placebo pill on a day when an active pill was required. By taking the wrong type of tablet, it increased their chances of getting pregnant while offering the assurance that they won’t. Out of the over one hundred women who have received the unwanted effects, 94 of them gave birth.
Now, they are seeking a jury trial, demanding damages, and some even seeking the appropriate amount of money that would help them raise their child up to the age of 18 years old. Reportedly, the sum reached “millions of dollars” from Qualitest Pharmaceuticals in over to cover both the physical and emotional trauma due to the faulty packaging of their products.
The lawsuit includes pills under brand names such as Cyclafem, Emoquette, Gildess, Orsythia, and Previfem. However, Endo Pharmaceuticals stated that they were only able to confirm selling the defective birth controls to only one patient. According to one of the company’s representatives, there have been precedents when courts have dismissed cases because the accuser could not prove that she had purchased a defective package.
This was also due to the fact that the pharmaceutical company has recalled most of those pills back in 2011. However, reports have it that both their “lot number and expiration dates” were hidden, which made it much harder for all women across United States to know if they have been affected.
The cases were filed only last week, so it remains to be seen how the matter will be resolved.
Image source: churchmilitant.com